Biotech News

Citing an anthrax scare and a recurring problem with safety, the Centers for Disease Control and Prevention on Friday shut down two research labs and stopped shipping highly dangerous germs to other labs.

Concluding its investigation into the unintended anthrax exposure at the Centers for Disease Control and Prevention in Atlanta, the CDC says it has found another more "distressing" problem due to lab workers not following protocol.

It may interest you to know that the price of a children's book hasn't wavered much at all in the... Years ago, my father said to me, 'Son, when the day comes that you find that special girl and you... This 1975 file electronmicrograph from the Centers for Disease Control shows the smallpox virus.

The Centers for Disease Control and Prevention also shut down two of its laboratories where the recent safety lapses took place.

The Frederick News-Post reported Friday that the agency says its $34 million contract with Charles River Laboratories International Inc. will end Sept.

Two members of the U.S. Senate Finance Committee, including Chairman Ron Wyden, on Friday asked Gilead Sciences Inc to defend the more than $80,000 cost of its breakthrough treatment for hepatitis C, citing the expense to federal healthcare programs.

The financ... )--E2open, Inc. , the leading provider of strategic, cloud-based software solutions for collaborative planning and execution across global trading n... )--Artisan Partners Asset Management Inc. today reported that its assets under management as of June 30, 2014 totaled $112.0 billion.

American conglomerates that want a piece of the tax-inversion deal bonanza may start turning to a new tactic.

The Biotechnology Industry Organization is reporting that an international confederation of biotechnology trade associations has created the International Council on Biotechnology Associations to advocate for public policies that support worldwide biotechnology growth.

The financially strapped Scripps Research Institute has decided it won't merge with or be acquired by the University of Southern California.

Swiss food giant Nestle announced Thursday that it had bolstered its hand in the medical skin treatment market by finalising a deal with Canada's Valeant Pharmaceuticals International.

Ohio sits in the middle of the pack when it comes to painkiller prescriptions, according to new data from the Centers for Disease Control and Prevention .

North American markets rallied as minutes from the latest meeting of the Federal Reserve indicated that the U.S. central bank plans to end its massive bond buyback program in October and is in no hurry to raise interest rates.

Credit Suisse AG has named senior banker Tom Davidson vice chairman of its global healthcare group, according to a memo released to employees on Wednesday.

The Department of Defense's Defense Advanced Research Projects Agency awarded Lawrence Livermore National Laboratory up to $2.5 million to develop an implantable neural device with the ability to record and stimulate neurons within the brain to help restore memory, DARPA officials announced this week.

Three workers at a New York pharmaceutical laboratory have received hospital treatment after being exposed to a potentially lethal chemical compound.

The two pop superstars were in Whistler last weekend for the wedding of their manager Scooter Braun, who discovered Bieber and Jepsen.

Shares of Celgene Corp. slipped in premarket trading Wednesday after the drugmaker said its psoriatic arthritis treatment Otezla missed the main goal of a late-stage study exploring an additional use.

In the 34 years Gary Roberts has been a pharmacist, he has never witnessed such large percentage increases in the cost of many generic drugs.

Sanofi SA, whose top-selling Lantus helps diabetics control blood sugar levels, has filed a lawsuit accusing Eli Lilly and Co of infringing seven patents related to insulin and devices used to deliver it.